The COVID-19 IgG and IgM Rapid Test accurately identifies the antibodies that develop after exposure to coronavirus — and delivers results in as little as 10 minutes.
Not all Covid-19 antibody tests are created equal. The Rapid Test exclusively offered by Premier Biotech is backed by research that demonstrates a 93% sensitivity rate. For details on the research, visit our Resources page.
On March 16, the U.S. government took an unprecedented step towards access to Coronavirus Disease (COVID-19) testing by allowing developers of certain tests to commercialize the products in the U.S. without the requirement for an FDA approval or Emergency Use Authorization (EUA)i. To comply with the regulation, the following statements must be included in any test reports using the COVID-19 Rapid Test: